Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone replacement in growth hormone deficiency associated with chronic heart failure
2016-004580-39Phase 3Completed
- Sponsor
- Policlinico Federico II
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), chronic heart failure (CHF), dilated cardiomyopathy (DCM), sponsored by Policlinico Federico II. Started Jun 2021; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)chronic heart failure (CHF)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on 2016-004580-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004580-39.